Stark, AKS, and the Florida CPOM Triangle

Most healthcare structuring mistakes in Florida don't come from missing a single rule. They come from solving for one regulator while forgetting the other two are watching the same arrangement from a different angle.

A Florida healthcare business sits at the intersection of three distinct bodies of law, each with its own logic, its own penalties, and its own enforcer. Federal physician self-referral law — the Stark Law — is strict-liability and unforgiving. The federal Anti-Kickback Statute (AKS) is intent-based and criminal. And Florida's corporate practice of medicine (CPOM) doctrine, together with the state's fee-splitting prohibition, governs who is even allowed to own and profit from the delivery of medicine in the first place. A structure that satisfies any one of them can still be fatally exposed under the other two.

This is the triangle every MSO platform, physician compensation model, and referral relationship in the state has to survive.

The three corners, briefly

Stark Law (42 U.S.C. § 1395nn). Prohibits a physician from referring Medicare/Medicaid patients for certain "designated health services" to an entity with which the physician (or an immediate family member) has a financial relationship — unless the arrangement fits squarely within an exception. Stark is strict liability: intent is irrelevant. If the arrangement doesn't fit an exception, the claim isn't payable, full stop.

Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)). Criminalizes knowingly paying or receiving anything of value to induce or reward referrals of federally reimbursable items or services. Unlike Stark, AKS turns on intent — and its safe harbors are voluntary, not mandatory. Failing to fit a safe harbor isn't automatically illegal, but it removes your protection and puts the focus squarely on why the arrangement was structured the way it was.

Florida CPOM & fee-splitting. Florida restricts the unlicensed ownership and control of medical practices and prohibits splitting professional fees with non-licensees (see Fla. Stat. §§ 458.331 and 817.505, among others). This is the corner out-of-state investors most often underestimate, because many states are far more permissive. In Florida, the question isn't just how money moves — it's who is allowed to receive it at all.

Where the corners collide: the MSO / friendly-PC structure

The standard answer to CPOM is the management services organization (MSO) paired with a physician-owned professional corporation (the "friendly PC"): the licensed physician owns the clinical entity, and a separately owned MSO provides management, administrative, and back-office services under a management services agreement (MSA) for a fee. Clean on paper. The danger is in the fee.

If the MSA fee is set as a percentage of practice revenue, you've potentially created a fee-splitting and CPOM problem under Florida law and handed an AKS theory to a regulator at the same time — because a revenue-linked management fee can look like payment for the referral stream the MSO's owners benefit from. Set the same fee at fair market value (FMV) for the actual services provided, fixed in advance and commercially reasonable without regard to volume or value of referrals, and you move toward safety under all three corners at once.

The fee is where Florida regulators have gotten more sophisticated. A percentage-of-collections MSA is no longer a structure you can assume nobody will look at.

Physician compensation: the second collision point

Inside the PC, how you pay physicians raises the same triangle. Productivity-based compensation is permitted and common — but the moment compensation is tied to the volume or value of a physician's referrals for designated health services, Stark is implicated and an exception (such as bona fide employment or personal services) becomes mandatory, not optional. Layer in any bonus tied to ancillary revenue and AKS intent questions follow close behind. The defensible models share three traits:

• Set in advance — the methodology is documented before the period it governs.
• Fair market value — supported by objective benchmarking data, not a back-calculation.
• Not referral-contingent — compensation does not vary with the volume or value of referrals for services the entity bills federal programs.

A practical sequence for getting it right

When I structure a Florida healthcare platform, the analysis runs in this order:

• Start with CPOM. Decide who can own the clinical entity and confirm the MSO/PC separation is real, not cosmetic. Get this wrong and nothing downstream is salvageable.
• Price the MSA at FMV. Fixed or FMV-based, commercially reasonable, supported by a defensible valuation — never a naked percentage of professional collections.
• Run every money flow through Stark and AKS. Map each financial relationship (compensation, leases, medical directorships, equity) to a Stark exception and, where referrals are in play, an AKS safe harbor.
• Document the FMV and commercial reasonableness. The contemporaneous file is what carries you through an audit or investigation years later.

None of these corners is negotiable on its own, and none can be solved in isolation. The work is holding all three in view at the same time — which is exactly what a Florida healthcare regulatory practice is built to do.